Emerging Treatment Options for Recurrent Ovarian Cancer: The Potential Role of Olaparib

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s30748
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Treatment Options in Recurrent Ovarian Cancer: Latest Evidence and Clinical Potential

Therapeutic Advances in Medical Oncology
Oncology
2014English

Profile of Olaparib in the Treatment of Advanced Ovarian Cancer

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2016English

Targeted Treatment of Recurrent Platinum-Resistant Ovarian Cancer: Current and Emerging Therapies

Cancer Management and Research
Oncology
2010English

Emerging Treatment Options for Patients With Recurrent Advanced Thymic Epithelial Tumors

OncoTargets and Therapy
OncologyPharmacology
2012English

Emerging Treatment Options for the Mucopolysaccharidoses

Research and Reports in Endocrine Disorders
2012English

Emerging Treatment Options for B-Cell Lymphomas

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods

Cells
2020English

Targeting Metastatic Colorectal Cancer &Ndash; Present and Emerging Treatment Options

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy